Table 1. The Baseline Characteristics and Angiographic Findings of the Study Population.
| Variable | CSFP (n = 62) | Controls (n = 44) | P-value |
|---|---|---|---|
| Age (years) | 56.7±8.6 | 55.5±8.2 | 0.49 |
| Male sex (%) | 36 (58%) | 19 (43%) | 0.13 |
| Heart rate (beat/min) | 66.0±9.2 | 68.8±7.6 | 0.10 |
| Disease course (month) | 43.5±55.5 | 43.6±53.7 | 1.00 |
| Systolic blood pressure (mm Hg) | 125.3±11.8 | 127.6±14.3 | 0.39 |
| Diastolic blood pressure (mm Hg) | 75.1±8.9 | 76.9±10.1 | 0.34 |
| Hypertension (HTN) (%) | 27 (44%) | 18 (41%) | 0.73 |
| Diabetes mellitus (DM) (%) | 4 (6%) | 1 (2%) | 0.31 |
| Fasting blood glucose (mmol/L) | 5.68±1.08 | 5.35±0.92 | 0.12 |
| LDL cholesterol (mmol/L) | 2.87±0.81 | 2.71±0.86 | 0.31 |
| Triglycerides (mmol/L) | 1.41±0.69 | 1.38±0.86 | 0.81 |
| HDL cholesterol (mmol/L) | 1.09±0.22 | 1.19±0.34 | 0.07 |
| Total cholesterol (mmol/L) | 4.40±0.94 | 4.34±0.91 | 0.76 |
| Medications: | |||
| ACEI/ARB (%) | 26 (42%) | 17 (38%) | 0.61 |
| Beta-blockers (%) | 35 (56%) | 22 (49%) | 0.42 |
| Calcium channel blocker (%) | 7 (11%) | 9 (21%) | 0.15 |
| Statin (%) | 51 (83%) | 33 (74%) | 0.19 |
| Nitrates (%) | 51 (82%) | 30 (68%) | 0.08 |
| TFC: | |||
| cLAD | 42.6±15.8 | 21.8±3.1 | < 0.001 |
| LCx | 36.9±17.1 | 21.6±3.9 | < 0.001 |
| RCA | 36.4±19.3 | 21.2±4.1 | < 0.001 |
| Mean | 38.6±13.5 | 21.5±2.3 | < 0.001 |
Values shown are Mean ± SD or percentage. TFC, thrombolysis in myocardial infarction frame count; LAD, left anterior descending coronary artery; LCx, left circumflex coronary artery; RCA, right coronary artery; LDL, low-density lipoprotein; HDL, high-density lipoprotein; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker.